Literature DB >> 20010876

Ezrin mediates c-Myc actions in prostate cancer cell invasion.

Y-C Chuan1, D Iglesias-Gato, L Fernandez-Perez, A Cedazo-Minguez, S-T Pang, G Norstedt, A Pousette, A Flores-Morales.   

Abstract

The forced overexpression of c-Myc in mouse prostate and in normal human prostate epithelial cells results in tumor transformation with an invasive phenotype. How c-Myc regulates cell invasion is poorly understood. In this study, we have investigated the interplay of c-Myc and androgens in the regulation of prostate cancer cell invasion. We found that c-Myc induces cell invasion and anchorage-independent growth by regulating ezrin protein expression in the presence of androgens. The activity of the ezrin promoter is controlled by androgens through c-Myc, which binds to a phylogenetically conserved E-Box located in the proximal promoter region. Besides, we also show that ezrin is an important regulator of c-Myc protein levels. These effects are achieved through androgen-induced changes in ezrin phosphorylation, which results in the regulation of downstream signals. These downstream signals involve the modulation of Akt and GSK-3beta activity resulting in increased c-Myc protein synthesis and inhibition of its degradation. In summary, we have shown a key role for ezrin as a mediator of c-Myc-induced tumorigenesis in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010876     DOI: 10.1038/onc.2009.442

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.

Authors:  Yiwei Li; Dejuan Kong; Zhiwei Wang; Aamir Ahmad; Bin Bao; Subhash Padhye; Fazlul H Sarkar
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

2.  CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.

Authors:  Mo Zhai; Lin Cong; Yaxin Han; Guanjun Tu
Journal:  Tumour Biol       Date:  2013-09-08

3.  Ezrin is associated with gastric cancer progression and prognosis.

Authors:  Li Li; Yuan-Yu Wang; Zhong-Sheng Zhao; Jie Ma
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

Review 4.  Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2013-07-12

5.  Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.

Authors:  Lijuan He; Nadia Shobnam; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2010-08-14

6.  [EEFSEC knockdown inhibits proliferation, migration and invasion of prostate cancer cells in vitro].

Authors:  B Xu; J Hao; Q Xie; N Sa; S Wang; X DU; H Lu; P Gao; G Shi; X Dong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

7.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

8.  Sterol regulatory element-binding protein 1 cooperates with c-Myc to promote epithelial-mesenchymal transition in colorectal cancer.

Authors:  Duanyang Zhai; Chunhui Cui; Lang Xie; Lianxu Cai; Jinlong Yu
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

9.  Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.

Authors:  Wolfgang A Schulz; Marc Ingenwerth; Carolle E Djuidje; Christiane Hader; Jörg Rahnenführer; Rainer Engers
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

10.  Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

Authors:  M R Milone; B Pucci; F Bruzzese; C Carbone; G Piro; S Costantini; F Capone; A Leone; E Di Gennaro; M Caraglia; A Budillon
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.